维普中文期刊产品整合服务
495篇 您的检索式:作者名="Kiechl"
    题名 作者 年代 出处 被引量
1Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes显示文摘Anna Zampetaki Stefan Kiechl Ignat Drozdov Peter Willeit Ursula Mayr Marianna Prokopi Agnes Mayr Siegfried Weger Friedrich Oberhollenzer Enzo Bonora Ajay Shah Johann Willeit Manuel Mayr 2010Circulation Research2010,,6:3
2Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction显示文摘Anna Zampetaki Peter Willeit Lindsey Tilling Ignat Drozdov Marianna Prokopi Jean-Marie Renard Agnes Mayr Siegfried Weger Georg Schett Ajay Shah Chantal M. Boulanger Johann Willeit Philip J. Chowienczyk Stefan Kiechl Manuel Mayr 2012Journal of the American College of Cardiology2012,,:2
3Prevalence of insulin resistance in metabolic disorders: the Bruneck Study显示文摘Bonora E Kiechl S Willeit J 1998Diabetes1998,47,10:2
4Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease显示文摘Stefan Kiechl Georg Schett Gregor Wenning Kurt Redlich Martin Oberhollenzer Agnes Mayr Peter Santer Josef Smolen Werner Poewe Johann Willeit 2004Circulation: Journal of the American Heart Association2004,,18:2
5Early clinical worsening in patients with TIA or minor stroke: The Austrian Stroke Unit Registry显示文摘J Ferrari M Knoflach S Kiechl J Willeit S Schnabl L Seyfang W Lang 2010Neurology2010,,2:2
6Hoechst 33342 induces apoptosis inhibits topoisomerase I, and alters TATA box binding protein/DNA complexes in HT-144 melanoma cells显示文摘Kiechle FL Zhang X 1999Arab J Lab Med1999,25,:1
7Osteoprotegerin is a risk factor for progressive atherosclemsis and cardiovascular disease显示文摘Kiechl S Schett G Wenning G 2004Circulation2004,109,18:1
8The postgenomic era.Implications for the clinical laboratory显示文摘Kiechle FL Zhang X 0,,:1
9Hoechst 33342 induces apoptosis in hepatoma cells and inhibits topoisomerase I in vivo 显示文摘Zhang X Kiechle FL 1998J Clin Ligand Assay1998,21,1:1
10Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from a large population study 显示文摘Wiedermann C J Kiechl S Dunzendorfer S 1999J Am Coll Cardiol1999,34,:1
11Osteoprotegerin is a risk factorfor progressive atherosclerosis and cardiovascular disease 显示文摘Kiechl S Schett G Wenning G 2004Circulation2004,109,:1
12Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study显示文摘Tsimikas S Kiechl S Willeit J 2006J Am Coll Cardiol2006,47,11:1
13Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes显示文摘Zampetaki A Kiechl S Drozdov I 2010Cire Res2010,107,6:1
14Population-based incidence rates and risk factors for type 2 diabetes in white individuals:the Bruneck Study显示文摘Bonora E Kiechl S Willeit J 2004Diabetes2004,53,7:1
15Mechanism of Hoechst 33342-induced apoptosis in BC3H-1 myocytes显示文摘Zhang X Kiechle FL 1998Ann Clin Lab Sci1998,28,2:1
16Infections,immunity,and atherosclerosis:Associations of antibodies to chlamydia pneumoniae,Helicobacter pylori,and cytomegalovirus with immune reactions to heat shock protein 60 and carotid or femoral atherosclerosis显示文摘Mayr M Kiechl S Willeit J 2000Circulation2000,102,8:1
17Toll-like receptor4 and atherogenesis显示文摘KIECHL S WIEDERMANN CJ WILLEIT J 2003Ann Med2003,35,3:1
18Carotid atherosclero-sis and coronary heart disease in the metabolic syn-drome:prospective data from the Bruneck study显示文摘Bonora E Kiechl S Willeit J 2003Dia-betes Care2003,26,4:1
19Toll - like receptor 4polymorphisms and atherogenesis 显示文摘Kiechl S Lorenz E Reindl M 2002N Engl J Med2002,347,:1
20Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae, immune reactions to heat shock proteins as a possible link between infection and atheroselerosis显示文摘Mayr M Metzler B Kiechl S 1999Circulation1999,99,12:1
返回顶部 每页显示:
共25页 首页 上一页 第1页 下一页 末页 /25 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费